Showing results (91-100 of 112) with videos related to
Sort By:
Pageof 12
Journal of Medicinal Chemistry|May 27, 2011
Phospshoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors: discovery and structure-activity relationships of a series of quinoline and quinoxaline derivativesNobuko Nishimura, Aaron Siegmund, Longbin Liu, et al.Gut|April 28, 2022
Diet or medication in primary care patients with IBS: the DOMINO study - a randomised trial supported by the Belgian Health Care Knowledge Centre (KCE Trials Programme) and the Rome Foundation Research InstituteFlorencia Carbone, Karen Van den Houte, Linde Besard, et al.Bioorganic & Medicinal Chemistry Letters|March 14, 2007
Synthesis, structural analysis, and SAR studies of triazine derivatives as potent, selective Tie-2 inhibitorsBrian L Hodous, Stephanie D Geuns-Meyer, Paul E Hughes, et al.Gastroenterology|January 11, 2018
Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's DiseaseGeert D'Haens, Severine Vermeire, Guy Lambrecht, et al.Bioorganic & Medicinal Chemistry Letters|December 9, 2008
Pyridyl-pyrimidine benzimidazole derivatives as potent, selective, and orally bioavailable inhibitors of Tie-2 kinaseVictor J Cee, Alan C Cheng, Karina Romero, et al.Lancet (London, England)|February 26, 2008
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trialGeert D'Haens, Filip Baert, Gert van Assche, et al.Therapeutic Advances in Gastroenterology|August 1, 2024
DOMINO trial post hoc analysis: evaluation of the diet effects on symptoms in IBS subtypesClaudia Di Rosa, Karen Van den Houte, Annamaria Altomare, et al.Journal of Medicinal Chemistry|January 27, 2007
Alkynylpyrimidine amide derivatives as potent, selective, and orally active inhibitors of Tie-2 kinaseVictor J Cee, Brian K Albrecht, Stephanie Geuns-Meyer, et al.Journal of Medicinal Chemistry|February 22, 2011
Discovery and optimization of a series of benzothiazole phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitorsNoel D D'Angelo, Tae-Seong Kim, Kristin Andrews, et al.Journal of Medicinal Chemistry|November 19, 2019
Discovery and in Vivo Evaluation of Macrocyclic Mcl-1 Inhibitors Featuring an α-Hydroxy Phenylacetic Acid Pharmacophore or BioisostereGwenaella Rescourio, Ana Z Gonzalez, Salman Jabri, et al.Pageof 12